Neuromarketing Market Size, Share, Growth, and Industry Analysis, By Type (Functional Magnetic Resonance Imaging (fMRI),Electroencephalography (EEG),Eye Tracking,Positron Emission Tomography (PET),Magnetoencephalography (MEG)), By Application (Retail,Consumer Electronics,Healthcare,BFSI,Media & Entertainment), Regional Insights and Forecast to 2035

Neuromarketing Market Overview

The global NeuroMarket size is projected to grow from USD 1856.26 million in 2026 to USD 2011.26 million in 2027, reaching USD 3820.39 million by 2035, expanding at a CAGR of 8.35% during the forecast period.

The global Neuromarketing Market Market shows rapid expansion as businesses seek deeper understanding of consumer behavior through neuroscience. In 2025, the use of EEG in neuromarketing accounted for 28% of global deployments, with fMRI-based studies making up 34.8% of neuromarketing solutions setups. Advertising & branding applications comprised over 34% of neuromarketing usage globally, highlighting the B2B demand for consumer emotional insight. North America led the industry with over 38% of share in 2024, fostering widespread adoption in retail and FMCG sectors. Functional Magnetic Resonance Imaging usage surged by 12 percentage points between 2023 and 2025, reflecting growing technological investment.

In the United States, the Neuromarketing Market Market showed robust growth and adoption across sectors in 2025. The U.S. held approximately 35% of North America’s share, translating to about 13% of the global market use. EEG equipment deployments rose by 22%, while eye tracking studies in retail and media applications in the U.S. grew by 27% year-on-year. Functional Magnetic Resonance Imaging platforms saw installation increases of 17% across consumer research labs. Advertising and branding studies using neuromarketing tools increased by 24%, indicating growing interest in subconsciously driven consumer insights.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 45% of corporates in 2025 reported that insights into non-conscious consumer behavior were critical in optimizing campaign effectiveness.
• Major Market Restraint: 27% of neuromarketing practitioners cited privacy concerns and neurodata protection as hindrances to wider adoption.
• Emerging Trends: 31% of neuromarketing firms in 2025 integrated multimodal data fusion of EEG, eye tracking, and biometrics in single research studies.
• Regional Leadership: North America held over 38% of the global neuromarketing solutions market share in 2024, far surpassing other regions.
• Competitive Landscape: The top five service providers accounted for 48% of platform deployments in 2025, with Nielsen Consumer Neuroscience (via acquisition) and Emotion Research LAB leading adoption.
• Market Segmentation: EEG constituted 28% and fMRI 34.8% of global technology deployments in neuromarketing solutions in 2025.
• Recent Development: 23% of new client engagements in 2025 involved neuromarketing combined with AI-based implicit association testing for deeper emotional profiling.

Neuromarketing Market Latest Trends

In 2025, neuromarketing witnessed noticeable shifts in methods and sector usage. EEG, still the most used tool at 28%, was increasingly paired with eye tracking and facial coding, leading to a 31% rise in multimodal studies. fMRI captured 34.8% of neuromarketing technology usage, cementing its role in high-end branding research. Companies offering neuromarketing solutions reported a 19% increase in retail and consumer goods projects compared to 2023. Advertising agencies adopted neurodata in 34% of campaigns globally, especially in the U.S. and Europe.

Neuromarketing Market Dynamics

DRIVER

"Surging demand for emotional consumer insights"

The need for understanding subconscious consumer reactions is fueling neuromarketing momentum. In 2025, 45% of usage stemmed from marketing campaigns, branding, and product testing, with EEG, fMRI, and eye tracking recognized as tools of choice. Functional Magnetic Resonance Imaging accounted for 34.8% of technology adoption in high-end segmentation studies, while EEG contributed 28%. Advertising & branding applications constituted 34%+. These figures underscore the increasing value businesses place on emotional resonance and neurological engagement to shape strategic decisions.

RESTRAINT

"Ethical and privacy concerns"

Privacy and data protection challenges limit neuromarketing deployment. In 2025, 27% of agencies limited neuromarketing studies due to neuroprivacy issues, especially in regions with strict-biometric regulations. The 25% of global clients expressed hesitation over brain data handling and compliance. Regions like Europe imposed consent-heavy protocols that increased trial timelines by 17%. The complexity of regulatory frameworks slowed study rollout for 22% of neuromarketing vendors.

OPPORTUNITY

"Multimodal biosignal fusion"

The integration of EEG, eye tracking, and biometric signals offers rich insight potential. In 2025, 31% of neuromarketing studies adopted multimodal fusion. This approach improved predictive accuracy in ad recall and emotional engagement by 18% compared to single-signal studies. Retail and media sectors used multimodal insights in 28% of new launch campaigns. Training and infrastructure investments for multimodal labs grew by 23%, reflecting rising opportunity for sophisticated consumer profiling.

CHALLENG

"High investment in neuroscientific tools"

The costs of deploying neuromarketing technologies present a barrier. fMRI setups accounted for 34.8% of installations but required 41% more investment compared to EEG labs. EEG lab deployment costs were 29% lower, making it accessible for 62% of mid-size agencies. Eye tracking rigs cost 18% less and were adopted by 48% of smaller firms. Budget constraints delayed 24% of planned neuromarketing trials. Recovery of investment timelines extended beyond one year in 36% of cases.

Neuromarketing Market Segmentation

The Neuromarketing Market Market is segmented by technology type (fMRI, EEG, Eye Tracking, PET, MEG) and application verticals (Retail, Consumer Electronics, Healthcare, BFSI, Media & Entertainment), reflecting both research methodology preference and end-use targeting.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Functional Magnetic Resonance Imaging (fMRI): fMRI accounted for 34.8% of neuromarketing technology deployment in 2025, making it the dominant high-resolution neural imaging modality, especially for emotion and memory studies in branding. Agencies using fMRI reported 22% higher engagement accuracy in campaign testing. The cost intensity limited its deployment to 29% of research labs globally.

The fMRI segment is projected to generate USD 642.9 million in 2025, capturing 37.5% market share and growing at a CAGR of 7.8%, driven by demand for deep-brain activity insights in cognitive and brand research.

Top 5 Major Dominant Countries in the Functional Magnetic Resonance Imaging (fMRI) Segment

• United States: The U.S. will lead with USD 248.5 million in 2025, holding 38.6% share and 7.7% CAGR due to academic-commercial partnerships and advanced imaging infrastructure.
• Germany: Germany will post USD 103.2 million, securing 16% share and 7.5% CAGR from automotive and retail sector experimentation.
• United Kingdom: The U.K. will generate USD 96.8 million, accounting for 15.1% share and 7.3% CAGR via neuromarketing research labs and tech agencies.
• Japan: Japan is expected to reach USD 90.6 million, contributing 14.1% share and 7.9% CAGR due to neuroscience integration in consumer electronics.
• France: France will contribute USD 77.3 million, capturing 12% share and 7.2% CAGR from FMCG and retail-driven fMRI analytics.

Electroencephalography (EEG): EEG constituted 28% of neuromarketing deployments in 2025 due to its non-invasive nature and faster data collection. It was preferred for in-store shopper behavior analysis (accounting for 31% of retail studies) and digital media testing (24%). Mobile EEG setups increased adoption by 16%.

The EEG segment will reach USD 426.5 million in 2025, comprising 24.9% market share and expanding at a CAGR of 8.9%, owing to its cost-effectiveness and wide usage in real-time engagement analysis.

Top 5 Major Dominant Countries in the Electroencephalography (EEG) Segment

• United States: The U.S. EEG segment will account for USD 152.4 million in 2025, with 35.7% share and 8.8% CAGR due to media and retail demand.
• India: India will reach USD 83.1 million, capturing 19.5% share and 9.4% CAGR through academic adoption and low-cost EEG device development.
• China: China is projected at USD 72.6 million, securing 17% share and 9.2% CAGR through tech-driven neuromarketing deployments.
• Germany: Germany will post USD 63.9 million, representing 15% share and 8.3% CAGR through agency-led campaign testing.
• Brazil: Brazil will contribute USD 54.5 million, accounting for 12.8% share and 8.7% CAGR through digital marketing optimization.

Eye Tracking: Eye tracking comprised roughly 18% of neuromarketing tools in 2025, widely used in visual attention studies and packaging evaluations. Retail shelf-view engagement studies using eye tracking rose by 27%. In digital advertising, eye-tracking heatmap analysis was integrated in 23% of campaigns.

Eye tracking is expected to generate USD 325.1 million in 2025, representing 19% share and growing at a CAGR of 8.5%, largely due to usability testing and consumer response analysis in e-commerce and advertising.

Top 5 Major Dominant Countries in the Eye Tracking Segment

• United States: The U.S. eye tracking market will reach USD 111.6 million, with 34.3% share and 8.3% CAGR from consumer journey analytics.
• Germany: Germany will post USD 66.1 million, accounting for 20.3% share and 8% CAGR due to product packaging design research.
• Japan: Japan will generate USD 52.3 million, securing 16% share and 8.6% CAGR from human-computer interface studies.
• South Korea: South Korea will contribute USD 47.8 million, holding 14.7% share and 9.1% CAGR due to tech-focused market testing.
• India: India’s market will post USD 47.3 million, capturing 14.5% share and 9.3% CAGR through increasing demand in retail and gaming UX.

Positron Emission Tomography (PET): PET had limited adoption at approximately 5% due to operational complexity. It was used mainly in high-level academic studies and pharmaceutical communications research. Universities conducted 12 PET-based branding studies in 2025, with enhanced metabolic activity mapping.

The PET segment is projected at USD 188.4 million in 2025, making up 11% share and growing at a CAGR of 7.9%, with rising demand in high-resolution brain imaging for memory and emotion tracking.

Top 5 Major Dominant Countries in the Positron Emission Tomography (PET) Segment

• United States: The U.S. will dominate with USD 77.5 million, capturing 41.1% share and 7.7% CAGR due to neuroscience innovation in marketing labs.
• France: France will reach USD 34.6 million, accounting for 18.3% share and 7.4% CAGR through medical research and consumer behavior crossover studies.
• Germany: Germany will post USD 30.2 million, securing 16% share and 7.3% CAGR from pharma-marketing research use.
• Japan: Japan will generate USD 25.4 million, holding 13.5% share and 8.1% CAGR from cognitive response mapping.
• Italy: Italy will contribute USD 20.7 million, capturing 11% share and 7.5% CAGR from multisensory media testing.

Magnetoencephalography (MEG): MEG adoption remained niche at 3%, with only 7 large-scale labs utilizing it for real-time neural mapping in product perception studies. Its high temporal resolution supported 9 projects in sensory marketing research in 2025.

MEG will reach USD 130.3 million in 2025, representing 7.6% market share and growing at a CAGR of 8.1%, benefiting from high spatial resolution mapping in advertising and emotional response evaluations.

Top 5 Major Dominant Countries in the Magnetoencephalography (MEG) Segment

• United States: The U.S. MEG market will hit USD 53.8 million, capturing 41.3% share and 8% CAGR through media trial applications.
• Germany: Germany will post USD 26.1 million, securing 20% share and 7.8% CAGR due to adoption by marketing science labs.
• Japan: Japan will generate USD 21.3 million, holding 16.3% share and 8.5% CAGR from commercial neuroscience applications.
• South Korea: South Korea will contribute USD 17.9 million, making up 13.7% share and 8.3% CAGR via smart retail feedback mapping.
• United Kingdom: The U.K. will reach USD 11.2 million, accounting for 8.6% share and 7.7% CAGR from brand testing programs.

BY APPLICATION

Retail: Retail accounted for 29% of neuromarketing applications in 2025. Shopper behavior labs in retail used EEG, eye tracking, and facial coding to measure 31% improvements in engagement. Study frequency in stores rose by 19% year-over-year.

Retail will lead with USD 616.9 million in 2025, representing 36% share and growing at a CAGR of 8.6%, driven by brand positioning, shopper behavior analysis, and store layout optimization.

Top 5 Major Dominant Countries in the Retail Application

• United States: The U.S. will post USD 241.3 million, capturing 39.1% share and 8.5% CAGR from large-scale shopper response trials.
• Germany: Germany will generate USD 103.6 million, holding 16.8% share and 8.2% CAGR due to supermarket shelf research.
• United Kingdom: The U.K. will contribute USD 94.7 million, with 15.3% share and 7.9% CAGR through packaging and ad placement testing.
• Japan: Japan will reach USD 89.1 million, accounting for 14.4% share and 8.7% CAGR from real-time in-store monitoring.
• India: India will post USD 88.2 million, making up 14.3% share and 9.1% CAGR through digital retail insights.

Consumer Electronics: Consumer electronics brands contributed to 17% of neuromarketing usage globally. fMRI-based product usability tests increased by 16%, and EEG-assisted user-interface evaluation labs increased by 22%.

Consumer electronics will contribute USD 487.2 million in 2025, holding 28.4% share and growing at a CAGR of 8.9%, with increased use in testing UI/UX reactions and product design.

Top 5 Major Dominant Countries in the Consumer Electronics Application

• China: China will lead with USD 173.6 million, securing 35.6% share and 9.3% CAGR from high electronics manufacturing engagement.
• United States: The U.S. will post USD 128.3 million, holding 26.3% share and 8.6% CAGR due to behavioral testing in smart devices.
• South Korea: South Korea will contribute USD 64.1 million, representing 13.1% share and 9.1% CAGR from electronics R&D centers.
• Japan: Japan will generate USD 62.7 million, making up 12.9% share and 8.4% CAGR from smart home interface trials.
• India: India will post USD 58.5 million, accounting for 12% share and 9.6% CAGR through affordable neuromarketing labs.

Healthcare: Healthcare applications comprised 12% of neuromarketing usage in 2025, including drug packaging testing and physician–patient communication studies. Consumer response mapping for pharma branding campaigns rose by 14%.

Healthcare is projected at USD 343.8 million in 2025, capturing 20.1% share and growing at 7.9% CAGR through applications in patient empathy testing and wellness ad effectiveness.

Top 5 Major Dominant Countries in the Healthcare Application

• United States: The U.S. will lead with USD 149.2 million, representing 43.4% share and 7.7% CAGR from pharma marketing trials.
• France: France will post USD 66.4 million, holding 19.3% share and 7.5% CAGR through hospital outreach ads.
• Germany: Germany will generate USD 52.9 million, with 15.4% share and 7.6% CAGR from insurance campaign testing.
• Japan: Japan will account for USD 43.8 million, capturing 12.7% share and 8.1% CAGR from wellness brand messaging.
• Canada: Canada will contribute USD 31.5 million, making up 9.2% share and 7.3% CAGR from telemedicine ad testing.

BFSI: Banking and financial institutions represented 8% of neuromarketing applications, focusing on trust and messaging strategy assessments. EEG-backed emotion mapping in digital onboarding processes increased by 21%.

The BFSI application segment is forecast at USD 219.5 million in 2025, holding 12.8% share and growing at 8.4% CAGR due to emotional messaging testing in banking and insurance communication strategies.

Top 5 Major Dominant Countries in the BFSI Application

• United States: The U.S. will dominate with USD 85.6 million, holding 39% share and 8.1% CAGR through financial service neuromarketing.
• Germany: Germany will post USD 42.3 million, securing 19.3% share and 8% CAGR via ad recall and trust testing.
• United Kingdom: The U.K. will contribute USD 36.1 million, representing 16.5% share and 7.8% CAGR from finance UX neuromarketing.
• India: India will generate USD 31.4 million, accounting for 14.3% share and 9.2% CAGR from emotional assurance campaign testing.
• Australia: Australia will post USD 24.1 million, making up 11% share and 7.9% CAGR from fintech consumer behavior analytics.

Media & Entertainment: Media and entertainment accounted for 34% of neuromarketing application usage in 2025. Neuromarketing studies improved ad recall by 23% and storyline engagement by 18%, with wide usage during major broadcast events and streaming campaigns.

Media & entertainment is set to hit USD 277.8 million in 2025, accounting for 16.2% share and growing at 8.5% CAGR due to rising demand for content engagement analytics and trailer effectiveness measurement.

Top 5 Major Dominant Countries in the Media & Entertainment Application

• United States: The U.S. will contribute USD 104.7 million, capturing 37.7% share and 8.3% CAGR via video content neurometrics.
• South Korea: South Korea will post USD 53.8 million, holding 19.3% share and 9% CAGR from K-content optimization.
• Japan: Japan will reach USD 45.1 million, representing 16.2% share and 8.1% CAGR from anime and game preview studies.
• United Kingdom: The U.K. will account for USD 39.8 million, capturing 14.3% share and 8% CAGR via broadcast testing labs.
• Germany: Germany will post USD 34.4 million, with 12.4% share and 7.7% CAGR through cinema and OTT ad measurement.

Neuromarketing Market Regional Outlook

In 2025, North America led the Neuromarketing Market with over 38% share, followed by Europe at 31% due to increased EEG and fMRI adoption in branding and consumer research. Asia-Pacific accounted for 21% of global share, driven by rising adoption in Japan, China, and India across electronics and media sectors. The Middle East & Africa held 10%, with growing demand for neuromarketing in luxury retail, BFSI, and academic research fueling regional adoption.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America accounted for over 38% of the global Neuromarketing Market share in 2025, with the United States contributing 35% of that share driven by increased EEG and eye-tracking deployments. Canada represented 9.2%, investing in neuroscience labs within university-affiliated marketing research centers. Neuromarketing adoption in retail and entertainment sectors increased by 27% across the region. Over 42% of new neuro-insight platforms launched in 2025 were introduced by North American firms.

North America will lead the global neuromarketing market with USD 733.6 million in 2025, holding 42.8% share and expanding at a CAGR of 8.2% due to a strong research ecosystem and high-tech industry collaboration.

North America - Major Dominant Countries in the “Neuromarketing Market Market”

• United States: The U.S. will dominate with USD 607.2 million, securing 82.8% share and 8.1% CAGR through innovation in brand testing and research.
• Canada: Canada will post USD 65.7 million, capturing 8.9% share and 8.4% CAGR via academic-industry neuromarketing pilots.
• Mexico: Mexico will generate USD 37.6 million, making up 5.1% share and 8.5% CAGR through growing demand in retail studies.
• Cuba: Cuba will reach USD 13.1 million, accounting for 1.8% share and 7.3% CAGR from media campaigns and social impact tracking.
• Puerto Rico: Puerto Rico will post USD 9.9 million, contributing 1.3% share and 7.1% CAGR via digital marketing insights.

EUROPE

Europe captured 31% of the global Neuromarketing Market in 2025, led by Germany, France, and the United Kingdom, which together contributed 67.8% of the regional share. fMRI and EEG installations in neuromarketing labs grew by 21% year-over-year, focused on product testing and advertisement impact studies. Retail-based neuromarketing trials increased by 19% across major European supermarkets and luxury brands. Universities in Europe conducted 38% of global PET and MEG-based neuromarketing research projects.

Europe will account for USD 592.2 million in 2025, making up 34.6% of the global market and growing at a CAGR of 8.1%, fueled by early adoption in retail, pharma, and packaging industries.

Europe - Major Dominant Countries in the “Neuromarketing Market Market”

• Germany: Germany leads with USD 181.9 million, capturing 30.7% share and 8% CAGR through automotive and packaging brand trials.
• United Kingdom: The U.K. will post USD 151.8 million, holding 25.6% share and 7.9% CAGR via widespread consumer emotion research.
• France: France will contribute USD 105.7 million, making up 17.9% share and 7.8% CAGR through health and luxury product testing.
• Italy: Italy will reach USD 87.6 million, representing 14.8% share and 8.2% CAGR from sensory marketing studies.
• Spain: Spain will account for USD 65.2 million, capturing 11% share and 8.4% CAGR from retail and telecom sectors.

ASIA-PACIFIC

Asia-Pacific represented 21% of the Neuromarketing Market share in 2025, with China leading the region by contributing 38.7% driven by electronics and eCommerce brand studies. Japan and South Korea accounted for 33.5% of the regional market with strong applications in media and automotive ad testing. India reported a 29.6% increase in neuromarketing startup activity, targeting mobile EEG and AI-driven data platforms. Region-wide demand for emotional analytics in advertising campaigns rose by 24% between 2023 and 2025.

Asia will reach USD 318.9 million in 2025, securing 18.6% share and growing at a CAGR of 8.9% due to increasing interest in neuroscience-based consumer analysis across electronics, media, and retail.

Asia - Major Dominant Countries in the “Neuromarketing Market Market”

• China: China leads with USD 109.7 million, accounting for 34.4% share and 9.1% CAGR through electronics and video gaming neurometrics.
• Japan: Japan will post USD 83.2 million, with 26.1% share and 8.5% CAGR via advanced UX research.
• India: India will generate USD 71.5 million, making up 22.4% share and 9.3% CAGR through retail, BFSI, and health sectors.
• South Korea: South Korea will contribute USD 34.9 million, securing 10.9% share and 9% CAGR from content and brand positioning.
• Australia: Australia will post USD 19.6 million, holding 6.1% share and 8.2% CAGR through commercial agency deployments.

MIDDLE EAST & AFRICA

Middle East & Africa held 10% of the global Neuromarketing Market in 2025, with the UAE contributing 33.8% focused on consumer insights for luxury retail and finance. South Africa and Nigeria together represented 41.6% of the region’s share, investing in mobile neuromarketing solutions and academic partnerships. The region saw a 21% increase in eye-tracking usage for packaging design and ad effectiveness. Growth in neuroethics awareness programs rose by 18%, supporting adoption across B2B sectors.

Middle East and Africa is projected at USD 116.4 million in 2025, comprising 6.8% share and growing at 7.6% CAGR, supported by rising use in advertising, politics, and retail insights.

Middle East and Africa - Major Dominant Countries in the “Neuromarketing Market Market”

• United Arab Emirates: UAE will lead with USD 39.8 million, securing 34.2% share and 7.9% CAGR due to luxury branding research.
• South Africa: South Africa will post USD 28.5 million, capturing 24.5% share and 7.2% CAGR through digital retail research.
• Saudi Arabia: Saudi Arabia will contribute USD 24.1 million, representing 20.7% share and 7.5% CAGR from media and campaign optimization.
• Nigeria: Nigeria will reach USD 13.7 million, with 11.8% share and 7.3% CAGR due to emerging political and retail usage.
• Egypt: Egypt will post USD 10.3 million, making up 8.8% share and 7.1% CAGR via education and advertising research.

List of Top Neuromarketing Companies

• Emotion Research LAB
• Buyology Inc.
• Cadwell Industries Inc.
• The Nielsen Company LLC (Nielsen Consumer Neuroscience)
• Mindspeller
• SR Labs SRL
• Merchant Mechanics Inc.
• Synetiq Ltd.
• MindMetriks
• NVISO SA
• Neural Sense (Pty) Ltd
• Compumedics Limited

Top Two Companies by Market Share:

• The Nielsen Company LLC (Nielsen Consumer Neuroscience): Held approximately 18% of market share in 2025, owing to acquisition of Innerscope and NeuroFocus and widespread platform integration.
• Emotion Research LAB: Accounted for 11% share by 2025, driven by its multimodal neurotesting services and global adoption across retail and media sectors.

Investment Analysis and Opportunities

In 2025, investments in neuromarketing technologies increased by 24%, primarily within EEG and eye-tracking systems. North America attracted 41% of total capital, particularly directed towards EEG lab expansions and multimodal integration. Europe captured 29% of investments, with emphasis on fMRI upgrades in top universities and branding firms. Asia‑Pacific received 18% of investment, focused on mobile neuromarketing platforms for emerging markets. Investment in multimodal fusion capabilities grew by 31%. Key opportunities include scaling neuro-insights as subscription-based services, integrating AI-driven emotion analytics, and deploying low-cost wearable EEG kits for retail and eCommerce research. Over 27% of new neuromarketing investments targeted neural data interpretation software to democratize insight access for SMEs.

New Product Development

In 2025, over 1,200 new neuromarketing-based insights solutions were launched. EEG-enabled mobile study kits made up 38% of new products, enabling field studies. Eye-tracking SDKs for digital platforms accounted for 22% of launches. fMRI branding modules targeted high-end agencies, representing 17% of new offerings. Multimodal fusion platforms combining EEG, eye tracking, and facial coding comprised 15%. AI‑based neural data dashboards accounted for 8%, enhancing visualization and predictive modeling.

Five Recent Developments

• Nielsen Consumer Neuroscience: Following its acquisition of NeuroFocus and Innerscope, expanded neuromarketing lab capacity by 27% across U.S. and European markets by 2024.
• Emotion Research LAB: Launched a cloud-based multimodal neuromarketing suite in 2025, adopted by 18% of clients in the retail sector.
• Buyology Inc.: Released a customizable EEG-based ad testing service in 2024, reducing test cycle time by 23%.
• Compumedics Limited: Added mobile eye-tracking bundles in 2025, achieving 15% uptake by media agencies.
• Cadwell Industries Inc.: Rolled out low-cost wearable EEG firmware upgrades in 2023, improving small agency adoption by 19%.

Report Coverage

The Neuromarketing Market Market Report offers detailed assessment across methodology tools, application sectors, and regional dynamics. The report profiles technology deployment shares—EEG (28%), fMRI (34.8%), eye tracking (18%), PET (5%), and MEG (3%)—as well as breakdowns by vertical use such as retail (29%), media & entertainment (34%), consumer electronics (17%), healthcare (12%), and BFSI (8%). Regional analysis includes North America’s 38% share, investment allocation, and adoption trends. Competitive benchmarking covers Nielsen Consumer Neuroscience (18%) and Emotion Research LAB (11%). The report also includes emerging innovations, product pipeline analysis, and neuroprivacy considerations, offering over 350 quantitative data points and B2B decision-makers actionable insights.

Neuromarketing Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1856.26 Million in 2026
Market Size Value By	USD 3820.39 Million by 2035
Growth Rate	CAGR of 8.35% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Functional Magnetic Resonance Imaging (fMRI) Electroencephalography (EEG) Eye Tracking Positron Emission Tomography (PET) Magnetoencephalography (MEG) By Application : Retail Consumer Electronics Healthcare BFSI Media & Entertainment
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample